4//SEC Filing
Calais Philippe 4
Accession 0001104659-22-073636
CIK 0001829635other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 8:27 PM ET
Size
5.5 KB
Accession
0001104659-22-073636
Insider Transaction Report
Form 4
Calais Philippe
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-22+9,500→ 9,500 totalExercise: $1.24Exp: 2032-06-21→ Common Stock (9,500 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 22, 2023 and (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time.
Documents
Issuer
Transcode Therapeutics, Inc.
CIK 0001829635
Entity typeother
Related Parties
1- filerCIK 0001693728
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 8:27 PM ET
- Size
- 5.5 KB